Authors

Sexual and Gender Minority Patients With Chronic Inflammatory Skin Diseases Affected by Obstacles to Care

Sexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.

Considerations to Best Serve Transgender Patients Seeking Aesthetic Care

Ronda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.

Q+A: Roflumilast cream 0.15% for AD with Eric Simpson, MD, MCR, FAAD

Eric Simpson, MD, MCR, FAAD, lead author of a recently-published article highlighting roflumilast cream 0.15%, joined us for a Q+A interview.

Cannabis Extract PHEC-66 Triggers Cell Death in Melanoma, Study Demonstrates

Researchers sought to expand knowledge of the role of cannabis and its molecular mechanisms in anticancer effects.

Addressing Unmet Needs Globally: LEO Pharma’s Commitment to Dermatology

Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.

Choosing a Biologic in Psoriasis With Ahmad Amin, MD, FAAD

Ahmad Amin, MD, FAAD, reviews biologic selection in patients with psoriatic disease.

Is OX40 Inhibition the Next Game Changer for Atopic Dermatitis?

Learn more about the OX40-OX40L pathway and 2 drugs heading toward phase 3 trials.

We are Biologic Coordinators of Dermatology (BCoD)

Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.

Nailing Common, Rare, and Scary Pediatric Nail Conditions and Surgeries

Jane Bellet, MD, will present 2 sessions full of pearls to ensure tiny fingers and toes are cared for in a timely, heartfelt, and effective treatment regimen.

AAD, Janssen, and Kenvue Partner to Mentor Next Generation of Dermatologists

Daphne Chan, PhD, MHEcon, discusses the Pathways program, a partnership between the AAD, Janssen, and Kenvue to mentor young, aspiring dermatology providers.

Study Reveals Majority of US Adults Distrust Health Care System’s Use of AI

A study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.

Closing the Gap in Pediatric Atopic Dermatitis: Experts Push for Steroid-Free Advancements

Discover the latest advancements in pediatric atopic dermatitis care, featuring expert insights on innovative treatments and family-centered management strategies.

Managing Your Pediatric Dermatology Practice and Life: Insights from Brandie Metz, MD, and Megha Tollefson, MD

Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.

The Evolving Role of Mohs Surgeons in Advancing Management of laBCC

OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?

Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.

ORKA-001 Advances Toward Yearly Dosing

ORKA-001 by Oruka Therapeutics offers promising yearly dosing for psoriasis, showcasing extended efficacy and safety in early clinical trials.

Michael Gold, MD, on Microneedling Optimization and Postprocedure Innovation

Discover how tailored pre- and postmicroneedling care, plus lactobacillus exosome boosters, may speed healing, improve scars, and deliver safe, FDA-cleared results.

Color as a Clinical Compass for Skin Cancer Detection

Orit Markowitz, MD, shares how a color-focused strategy helps spot early malignancies—even 2-mm lesions—across all skin tones.

Dermatology NP Practice is Evolving as Demand Increases

There are more than 355,000 nurse practitioners licensed in the United States in a variety of practice areas.

Vitiligo Linked to Insomnia Risk

A new study showed about half of all vitiligo patients from a care system were burdened with the sleeping disorder.

Rapid Itch Relief and Quality-of-Life With Next-Generation Oral TYK2 Inhibitors in Psoriasis

April Armstrong, MD, MPH, discusses the role of itch as a key driver of psoriasis burden and shows how next-generation oral TYK2 inhibitors like envudeucitinib provide rapid symptom relief and meaningful improvements in quality of life.

Shin Guard Dermatitis: What's the Diagnosis?

A new allergen, acetophenone azine with generalized autoeczematization, is the cause of “shin guard dermatitis.”

Hidradenitis Suppurativa: Immune Pathways and Evolving Interventions

HS is frequently misdiagnosed for 7 to 10 years because its symptoms resemble conditions like inflamed epidermal cysts, nodulocystic acne, and furuncles.

Cosmetic procedure complications in darker skin

Some adverse reactions to cosmetic procedures occur more often in patients with darker skin types. Patients should be counseled on appropriate cosmetic procedures for their skin type, according to Cheryl M. Burgess, M.D., at the Skin of Color Update virtual meeting.